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Consensus statement on iodine
deficiency disorders in Hong Kong
This article reviews the available data on the study of iodine deficiency
disorders in Hong Kong and to discuss the approach towards preventing
such disorders in Hong Kong. The importance of iodine and iodine deficiency
disorders is described, and the available data on the dietary iodine intake
and urinary iodine concentration in different populations of Hong Kong are
summarised and discussed. Dietary iodine insufficiency among pregnant
women in Hong Kong is associated with maternal goitrogenesis and
hypothyroxinaemia as well as neonatal hypothyroidism. Borderline iodine
deficiency exists in the expectant mothers in Hong Kong. Women of
reproductive age, and pregnant and lactating women should be made aware
and educated to have an adequate iodine intake, such as iodised salt, as an
interim measure. A steering group involving all stakeholders should be
formed to advise on the strategy of ensuring adequate iodine intake, including
universal iodisation of salt in Hong Kong. Continuous surveillance of
iodine status in the Hong Kong population is necessary.
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Introduction
Iodine is an important trace element and an essential substrate for the synthesis
of thyroid hormones. Tri-iodothyronine (T3) and tetra-iodothyronine (T4) are
iodinated molecules that exert diverse effects on cellular metabolism, growth,
and development, especially of the brain. Throughout the world, iodine deficiency
is the most important preventable cause of brain damage and mental retard-
ation, and affects a total of one billion people.1
The problem of iodine deficiency disorders has been overlooked in Hong
Kong because of misconceptions and wrong assumptions. To tackle this problem,
a Consensus Development Conference was held in Hong Kong on 3 October
2002, attended by Prof CJ Eastman, Asia-Pacific Representative of the
International Council for the Control of Iodine Deficiency Disorders (ICCIDD),
World Health Organization (WHO) as the overseas expert for the development
of a consensus statement. This conference was followed by an open forum on
1 December 2002, which was attended by Prof BS Hetzel, founding member
of the ICCIDD.
This paper presents the scientific data collected on the study of iodine defi-
ciency disorders in Hong Kong, and summarises the discussions and consensus
made during the expert panel meeting and open forum.
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The importance of iodine and iodine deficiency
disorders
Iodine deficiency has deleterious effects on individuals,
especially pregnant women and growing children. Table 1
shows the spectrum of clinical and subclinical manifestations
of iodine deficiency, which are collectively referred to as
iodine deficiency disorders.2 In areas of endemic goitre and
cretinism, the problem of iodine deficiency is not difficult
to recognise, because it leads to goitre, hypothyroidism,
mental deficiency, and impaired growth. Milder forms of
iodine insufficiency exist in non-goitrous aspects, such as
maternal goitrogenesis and hypothyroidism, increased
pregnancy loss, increased perinatal and infant mortality,
neonatal hyperthyrotropinaemia, neonatal hypothy-
roidism, and irreversible neuropsychological impairment
in children.3 The most critical period is from the second
trimester of pregnancy to the third year after birth.4-7
Since the establishment of the ICCIDD in 1986, there
has been growing awareness of iodine deficiency as a major
preventable cause of mental retardation. Recognising the
importance of preventing iodine deficiency disorders, the
World Health Assembly in 1991 adopted the goal of
eliminating iodine deficiency as a public health problem by
the 2000. In 1990, the world’s leaders, including those of
China, endorsed this goal when they met at the World
Summit for Children at the United Nations. The goal was
reaffirmed at the International Conference on Nutrition in
1992. The recommended daily iodine intake is shown in
the Box.8
Identification of the occurrence of iodine
deficiency disorders
Because dietary iodine intake is difficult to ascertain,
outcome indicators are used to provide a measure of iodine
deficiency. These indicators can be categorised according
to whether the assessments are clinical (thyroid size,
preferably by ultrasound, and cretinism) or biochemical
(levels of urinary iodine and thyroid-related hormones).
Table 2 summarises the indicators recognised by ICCIDD
for iodine deficiency and the cut-off prevalence criteria
for grading the level of severity of iodine deficiency in a
community.9
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Table 2. Summary of iodine deficiency disorder prevalence, by severity of public health problem, according to indicator and
target population9
* Different assays may have different normal ranges
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Iodine intake and urinary iodine concentration in
Hong Kong
A study performed in 1995 found that 45.3% of children,
51.7% of adults, and 55.3% of the elderly in Hong Kong
had a fasting urinary iodine concentration below the cut-
off level of 100 µg/L (0.8 µmol/L), which is used by the
WHO to signify iodine sufficiency.10 The proportion of
local children, adults, and elderly with a urinary iodine con-
centration below 50 µg/L (0.4 µmol/L)—the cut-off value
for severe iodine insufficiency—was 17.0%, 16.3%, and
20.0%, respectively. These data suggested that the
dietary iodine intake is just adequate among children but
of borderline sufficiency among adult populations.
To evaluate the problem of dietary iodine insufficiency
during pregnancy, a cross-sectional study of 253 healthy
southern Chinese pregnant women and their neonates was
conducted in Hong Kong in 1996.12 The results demonstrated
borderline iodine intake for high proportions of the
population, with 35.8% of pregnant women having a urinary
iodine concentration of less than 100 µg/L.
Another cross-sectional survey performed between
1996 and 1997 among 476 adolescent secondary-level
schoolchildren, however, did not show evidence of iodine
deficiency.11 The median urinary iodine concentration was
190 µg/L. It is unclear why there is such a discrepancy
between the two studies. Whether it is related to the iodine
assay, sample population, or a temporal difference is un-
clear. The overall evidence suggests that dietary iodine
intake among children and adolescents is higher than that
among adults in Hong Kong. The results also stress that
using the level of urinary iodine excreted as a measure of
iodine deficiency should be interpreted in the context of
median urinary iodine excretion of the population studied.
Furthermore, the results should not be inferred to other
populations, even if the median urinary iodine excretion is
more than 100 µg/L.
With the exception of the prospective study on pregnant
women, which was done between 1996 and 1998, all studies
on urinary iodine were performed before 1997. Whether
there could be a temporal change in the dietary iodine intake
of the Hong Kong population or a change in the dietary
fads among different age-groups during the past 5 years is
uncertain.
Goitre incidence in children in Hong Kong
The prevalence of clinical goitre among schoolchildren has
been widely adopted as a population-level indicator of
iodine deficiency8: a total goitre rate of 5% or more indicates
that iodine deficiency is a public health problem in that
area. A study of schoolchildren in a selected region of
Hong Kong noted a total goitre rate by palpation of 3.5%.11
The specificity and sensitivity of palpation are low, however,
and misclassification can be as high as 40%. The ICCIDD
have suggested that low goitre rates should be confirmed
by ultrasonography.8
Transient neonatal hypothyroidism
A pointer to possible dietary iodine insufficiency in Hong
Kong is the high proportion of newborns with increased
levels of cord blood thyroid-stimulating hormone (TSH;
thyrotropin), and the high incidence of transient neonatal
hypothyroidism. In 1982, the Queen Mary Hospital launched
a neonatal thyroid-screening programme, in which cord
blood TSH levels were determined.13 Data from this
programme initially revealed that the mean cord blood
TSH value was 7.0 mIU/L. Half of neonates had a cord
blood TSH level of more than 5.6 mIU/L, and approxi-
mately 22% of neonates had values of more than 10 mIU/L
(equivalent to a whole blood TSH value of 5 mIU/L). The
median TSH value for all 33 541 cord blood samples
collected at the Queen Mary Hospital during 1995 and
2001 was 6.37 mIU/L, with 22% of samples exceeding
10 mIU/L (unpublished data, Dr S Tam, Clinical Bio-
chemistry Unit, Queen Mary Hospital).
Random analysis of 8728 cord blood samples collected
by the Hong Kong Department of Health in 2001 showed a
median TSH value of 5.9 mIU/L, with 19% of the samples
having a TSH level of more than 10.0 mIU/L (unpublished
data, Dr P Hung, Department of Health). In other iodine-
sufficient or iodine-replenished areas, the proportion of
babies with elevated TSH values (>5 mIU/L in whole blood
samples or >10 mIU/L in serum samples) as detected through
the neonatal screening programme is less than 3%.8 It is a
concern that TSH levels are higher in cord blood than in
samples obtained on days 2 to 5 by heel prick. Although
generally true, this finding does not negate the use of cord
blood TSH as a useful indicator and tool for monitoring
iodine sufficiency in the population.8 The ICCIDD also
state that the cut-off value for neonatal TSH of 5 mIU/L
in whole blood applies to both samples obtained from
cord blood and on days 2 to 5.
In Hong Kong, approximately 23% of cases of congenital
hypothyroidism detected by the neonatal thyroid screening
programme were transient in nature.13,14 The cause of the
transience was not attributed to transplacental transfer of
inhibitory antibodies against the TSH-receptor.15 In iodine-
sufficient areas, the incidence of transient neonatal
hypothyroidism is low—for example, in the United States,
only 2% of cases with congenital hypothyroidism are
transient in nature.16
Maternal goitrogenesis, hypothyroxinaemia, and
foetal hypothyroidism
Pregnancy increases the maternal requirement for iodine
intake because of the increased clearance of iodine from the
kidneys, as well as the transfer of iodine and iodothyro-
nines to the foetus.17 Previous studies conducted in Europe
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revealed that a marginally low iodine intake of less than
50 mg/d was sufficient to pose a significant challenge to
both the maternal and neonatal thyroid gland, resulting
in goitre formation in the mother and hypothyroidism in
the neonate.18
A cross-sectional study performed on 253 healthy
pregnant women in Hong Kong12 showed that borderline
iodine intake had the following substantial effects on
both maternal and foetal thyroid function:
(1) A negative correlation between maternal serum TSH
concentration and urinary iodine concentration;
(2) A higher cord blood TSH level in infants whose
mothers had a low urinary iodine concentration
compared with infants whose mothers had normal
urine iodine concentrations; and
(3) Women who had given birth to infants with a cord
blood TSH level of at least 16 mIU/L had lower
urinary iodine concentrations and serum free T4
levels than did women who had given birth to infants
with normal cord TSH levels, and their infants also
had higher cord blood thyroglobulin levels.
To further evaluate the impact of iodine insufficiency on
pregnant women and their neonates in Hong Kong,
a prospective study was undertaken from 1996 to 1998.19 A
total of 230 healthy women were followed from the first
trimester of pregnancy until 3 months after delivery. Urinary
iodine excretion was increased from the first trimester
onwards, with the median urinary iodine concentration
being 0.84, 0.91, and 0.98 µmol/L in the first, second, and
third  trimester, respectively.19 Circulating thyroid hormone
levels declined progressively with increasing gestation;
levels of free T4 and free T3, and the free thyroxine index
(FTI) were subnormal at term in 53%, 61%, and 5% of
the mothers, respectively. Furthermore, the TSH level was
doubled at term. Overall, the thyroid volume, as determined
by ultrasonography, was increased by 30% between the
first and the third trimesters. One quarter of the pregnant
women at term demonstrated goitre enlargement according
to the WHO cut-off volume of 18 mL. In contrast, studies
conducted in areas with adequate iodine intake because of
national dietary iodine supplementation programmes, such
as the United States, have shown no enlargement of the
thyroid gland or, at most, enlargements of less than 5%
during pregnancy.20 In Hong Kong, the change in thyroid
volume in women during pregnancy was correlated
negatively with urine iodine concentrations (r= –0.15;
P<0.02) at term.19 Some 6% of these women showed
excessive thyroidal stimulation, as evidenced by lower
serum FTI and higher thyroglobulin levels when com-
pared with women without evidence of thyroidal stimulation.
In addition, these women with thyroidal stimulation
had lower urine iodine concentrations, a lower serum FTI
but higher thyroglobulin and free T3 to free T4 ratios, as
well as a larger thyroid volume throughout pregnancy.
Their neonates also had higher cord blood level of TSH
and thyroglobulin, as well as a slightly larger thyroid volume.
One half of neonates had subnormal free T4 levels at
birth. Women with excessive urinary iodine loss during
pregnancy are more likely than others to develop new
thyroid nodules during the second and third trimesters
of pregnancy.21 Thus, pregnancy in a borderline iodine-
sufficient environment results in maternal hypothyro-
xinaemia, maternal goitrogenesis, neonatal hypothyro-
xinaemia, hyperthyrotropinaemia, and thyroid hyperplasia.
Elimination of iodine deficiency disorders in
Hong Kong
Overall, collective evidence indicates that although the
dietary iodine intake of the Hong Kong population is
borderline sufficient, it is inadequate to meet extra re-
quirements at times of thyroidal stress, such as during
pregnancy, neonatal period, and possibly the first few
years of child growth. It is important to recognise the
existence of iodine deficiency, however mild, during
pregnancy. A mild degree of maternal iodine deficiency
and maternal hypothyroidism during pregnancy can result
in poorer psychological and neurological performance
in the child, as well as neonatal hypothyroidism.22-24
Transient low levels of circulating T4 at the critical stage
of brain development in the newborn has been shown to
result in an intelligent quotient (IQ) loss of 5 to 10 points.25
Strategy to increase iodine intake
Few places in this world can ensure an adequate population-
level intake of dietary iodine through natural food sources.
The majority of the world’s population achieves adequate
iodine intake through national supplementation pro-
grammes, which commonly include the addition of iodine
to the salt supply. Universal salt iodisation means the
iodisation of all human and livestock salt, including salt
used in the food industry. The ICCIDD advocated universal
salt iodisation as the ultimate approach towards elimi-
nating iodine deficiency disorders. In 1993, WHO and
UNICEF recommended this approach as the main strategy
to achieve elimination of iodine deficiency.26
Salt iodisation involves the addition of a small amount
of iodine (20-100 mg of iodine per kilogram of salt, or
20-200 parts per million [ppm]) in the form of potassium
iodate rather than potassium iodide, owing to the greater
stability of the former compound.27 Supplementation by salt
iodisation in populations with iodine deficiency disorders
has resulted in effective clinical improvement and con-
siderable reduction in all manifestations of iodine
deficiency, including cretinism and goitre.28,29 Currently,
75% of affected countries have legislation relating to salt
iodisation, and 68% of affected populations have access to
iodised salt. In China, legislation enforcing universal
iodisation of salt was passed in 1996; in southern China
and Guangzhou, with the government subsidy, salt has
been iodised at 20-50 ppm with the aim of maintaining a
level of 20 ppm at the consumer level.30 Offering iodised
Expert Panel Group on Iodine Deficiency Disorders in Hong Kong
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salt only to high-risk groups, such as pregnant women
and young children, would be only a temporary measure,
because this policy is expected to be non-sustainable.
Another problem with this policy is that iodised salt is
given only after women become pregnant. Iodine sup-
plementation has to be done early, because treatment
initiated in the third trimester can improve brain growth
and developmental achievement, but has no influence on
the neurological status of the affected child.6 In addition,
early iodine supplementation can prevent goitre develop-
ment in both the pregnant mother and the foetus.31
According to WHO recommendations, the daily iodine
intake for pregnant and lactating women should be
200 µg.8 The United States recommended in 2001 that
a daily iodine intake should be 220 µg and 290 µg for
pregnant and lactating women, respectively.32
Iodine supplementation during pregnancy is essential in
Hong Kong because seafood is not commonly consumed.10
Currently, no programme exists to eliminate iodine de-
ficiency in Hong Kong, as a result of the assumption that
such a deficiency is non-existent and the concern that a
high incidence of juvenile Graves’ disease may be related
to a high intake of iodine in adolescent children.33 Al-
though high iodine intake is associated with a higher
relapse rate of Graves’ disease,34,35 no published evidence
demonstrates that increases in iodine intake cause this
disease. In fact, the incidence of hyperthyroidism due to
nodular goitre and the incidence of Graves’ disease de-
creased in Switzerland after the gradual iodisation of salt
from 7.5 ppm to 15.0 ppm.36 A similar phenomenon was
observed in Denmark and Spain, with a reduction in the
incidence of subclinical hyperthyroidism both in children
and adults.37-39 The tolerable upper limit of iodine intake
is set at 1100 µg/d by the WHO.40
There is also concern that an increase in iodine in-
take may result in an increased incidence of thyroid dys-
function—namely, iodine-induced hyperthyroidism41
and iodine-induced hypothyroidism.42 Iodine-induced
hyperthyroidism is seen in certain individuals residing in
low–iodine intake regions when their intake of iodine is
more than what they are accustomed to, particularly in the
presence of existing nodular changes in the thyroid gland.
An increased incidence of hyperthyroidism following the
introduction of iodised salt has been reported in severely
iodine-deficient countries.41 However, populations in these
areas were exposed to iodine excesses largely because of
poor monitoring of the quality of iodised salt and of the
population’s iodine intake. The incidence of iodine-
induced hyperthyroidism during national iodine prophy-
laxis programmes in many countries has been low, and
usually disappears several years after the initiation of
the programme.40,43 Hence, iodine-induced hyperthy-
roidism should not be regarded as a contra-indication to
an iodisation programme, given the enormous long-
term benefits of the elimination of iodine deficiency on
the whole population. A systematic, closely monitored
programme in which the level of iodine in salt increases in
small increments can minimise the problem of iodine-
induced hyperthyroidism.
Iodine-induced hypothyroidism, which can develop
through a habitual intake of large amounts of iodine
(1-43 mg/d, which is 10-43 times the daily requirement)
has been reported in only two places in the world:
Hokkaido, Japan,42,44 and Gaojiabu Village, Shaanxi
Province, China.45
Experience from China on universal salt
iodisation
About half the world’s cases of iodine insufficiency occur
in China. Salt iodisation programmes in China began in
1994, and legislation on universal salt iodisation was
implemented in the country 2 years later. All salt is
currently iodised at 40 to 50 ppm. According to national
surveillance data, the total goitre rate in 9- to 10-year-old
schoolchildren decreased from 20.43% in 1995 to 10.86%
in 1997, accompanied by an increase in the quality of
household iodised salt from 39.9% to 81.1%,30 and an
increase in IQ by nine to 11 points in the endemic area.
According to a WHO report in 1998, implementation of the
national plan to eliminate iodine deficiency disorders in
China is a great example to other countries of what can be
done and will serve as a milestone in modern public health
achievements. The key to achieving this success was the
development of a strategy to involve the government and
major stakeholders; training of Chinese personnel, education
of the public about iodine deficiency; universal salt iod-
isation; and implementation of an appropriate monitoring
system to collect data on salt iodine content, urinary iodine
levels, and (recently) neonatal TSH levels. There has been
no increase in the incidence of hyperthyroidism after
iodisation in areas of iodine deficiency, mild excess, or
excess.46 These results confirm the believe that salt iodisation
at appropriate levels and adequate monitoring is unlikely
to give rise to iodine-induced hyperthyroidism.
Iodised salt in Hong Kong
Although most of the salt supply in Hong Kong comes from
the southern provinces of China, a survey conducted by the
Hong Kong Consumer Council in 1998 on local brands of
salt available in supermarkets and grocery stores showed
either no iodisation or low levels of iodisation.46 According
to a survey conducted by the Food and Environmental
Hygiene Department in 2002, salt available in Hong Kong
is predominantly not iodised. Only 15 (21%) of 72
brands of food salt contain iodine at a concentration of
3.6 to 64.0 ppm. There is currently no specific requirement
for salt iodisation in Hong Kong. No data are available on
whether iodised salt is being used by the food industry or
the iodine content of the salt used. There is also no good
quality and comprehensive survey on eating habits and use
of iodised salt among different age-groups in Hong Kong.
Hong Kong Med J Vol 9 No 6 December 2003      451
Iodine deficiency disorders in Hong Kong
Overall, the iodine intake of the Hong Kong population
should be brought up to—but not exceed—the level at which
iodine deficiency disorders can be avoided. Health care
policies are urgently needed to establish intervention
programmes that are aimed at achieving a relatively uniform
iodine intake while avoiding deficient or excessive iodine
intake in subpopulations. Until then, at-risk subpopula-
tions, including pregnant and lactating women and young
children of up to the age of 3 years, should receive a physio-
logical dose of potassium iodate supplementation.
Suggestions
The expert panel made the following suggestions at the
consensus meetings:
(1) Assessment of the situation
Although the available data suggest the existence of iodine
insufficiency among pregnant women and their newborns,
the situation among young children is less clear. The follow-
ing assessments are urgently needed in Hong Kong:
(a) To confirm the goitre rate among schoolchildren
and women of reproductive age by ultrasound
assessment, and to compare thyroid volumes with
age- and body-size–adjusted values obtained
from iodine-repleted populations. Schoolchildren
could be surveyed during their routine health
screening, which is currently conducted by the De-
partment of Health. Healthy women of childbear-
ing age and young children could be surveyed at
maternal and child health clinics or the Well Women
Clinic of the Department of Health;
(b) To monitor regularly the urinary iodine concen-
tration among high-risk groups—namely school-
children, women of reproductive age (18-44 years),
and neonates. A standardised method of urinary
iodine measurement should be adopted, and the
monitoring should preferably be conducted by the
Department of Health;
(c) To monitor results of the neonatal TSH screening
programme to track temporal changes; and
(d) To conduct a comprehensive survey on iodine
content of food items, especially food salt, in Hong
Kong.
(2) Development of an action plan
A multidisciplinary and intersectoral task force group
should be established to eliminate the problem of iodine
deficiency disorders in Hong Kong and to address the
need for legislation or regulation for universal salt iodisa-
tion. This task force group should involve all stakeholders,
as follows:
(a) Government officials;
(b) Health policy–makers;
(c) Salt producers, salt importers and distributors,
and food manufacturers;
(d) Concerned lay groups;
(e) The Consumer Council; and
(f) Nutrition, food, and medical professionals and
scientists, and other key opinion leaders.
(3) Concerns
Some concerns regarding legislation on universal salt
iodisation in Hong Kong are as follows:
(a) Matters related to public health issues;
(b) No specific group in the population should be
jeopardised by this legislation; for example, people
with a history of hyperthyroidism should have
access to non-iodised salt; and
(c) Freedom of choice in the society.
(4) Interim measures
(a) Public education and health promotion activities are
needed to improve awareness of iodine deficiency
disorders, in both the public and medical profession.
The first target subpopulations are schoolchildren,
pregnant and lactating women, as well as women of
reproductive age;
(b) While waiting for a strategy to ensure adequate
iodine intake, including universal iodisation of salt,
all pregnant and lactating women should be
advised to increase their dietary iodine intake to not
less than 200 µg/d. This level can be achieved by
either prescription of potassium iodide tablets or
through the intake of salt iodised at 10 to 20 ppm.
However, this approach is only an interim measure
and is unlikely to be sustainable; and
(c) Food labelling to increase public awareness of
iodine deficiency and of the need to increase dietary
iodine through natural food sources.
Consensus summary statement
Borderline iodine deficiency exists in the expectant mothers
in Hong Kong. Women of reproductive age and pregnant
and lactating women should be made aware and educated
to have an adequate iodine intake—for example, by using
iodised salt—as an interim measure. A steering group
involving all stakeholders should be formed to advise on
the strategy of ensuring adequate iodine intake, including
universal iodisation of salt in Hong Kong. Continuous
surveillance of iodine status in the Hong Kong population
is necessary.
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Coming in the February 2004 issue of
the Hong Kong Medical Journal
 Screening of vestibular schwannoma by magnetic resonance imaging
 Minimal invasive parathyroidectomy by unilateral neck dissection
 The effects of acute sleep deprivation on performance among medical residents
 Learning from other people’s mistakes
